News

The study found lifetime per-patient savings from early TAVR ranged from about $2,334 in the U.K. to $19,607 in Switzerland.

family caregiver

$2M says home-based caregivers could use a little more AI in their day-to-day lives.

money maze payment reimbursement

ACR, SIR and others altogether representing over 100,000 physicians recently wrote to 5 of the 7 Medicare Administrative Contractors to voice their concerns. 

vituity

Northern California-based Vituity, which is led and owned by doctors, said it has reached a deal to partner with Focused Medical Imaging. 

UCLA Health

“Becoming an independent department elevates this work and strengthens UCLA’s role in shaping the future of precision health," said the department's new acting chairman. 

RapidAI's opportunistic aortic management tool earns FDA clearance

The solution can assess the aorta on any CT scan that offers visualization of it, including post-treatment and unenhanced noncontrast studies. 

physician tracking patient data and reporting on outcomes

In a report, News Center Maine spoke to a personal injury attorney who said she often receives numerous copies of medical records for her clients, each with its own fee. She said she is glad someone decided to sue over the issue, which may violate state law capping patient record-sharing costs.

Medical malpractice gavel diagnostic error mistake stethoscope

According to a lawsuit, Jasmine Vincent, 15, was diagnosed by providers at MainHealth’s Mid Coast Medical Group with gynecomastia—a condition that typically affects males. She later died of leukemia-related cardiac arrest. Her mother was awarded $25 million in damages.

ALS drug repurposed for PET imaging

Researchers radiolabeled the drug so that they could follow its movement and breakdown in the body to help visualize areas of oxidative stress.

self-centering guide catheter (SCGC) for TAVR from Boston Scientific

The new Self-Centering Guide Catheter was designed to help care teams with the retrograde crossing of the aortic valve during TAVR. Researchers evaluated the safety and effectiveness of the catheter, sharing their experience in JACC: Cardiovascular Interventions.

Thumbnail

Tenecteplase is a tissue plasminogen activator given to patients through a single five-second intravenous bolus. It is only the second drug of its kind to gain FDA approval, and the first in many years.

Artificial intelligence AI in healthcare news

Medical device companies navigating regulatory pathways should know: Large language models are not reliable guides. 

Around the web

The study found lifetime per-patient savings from early TAVR ranged from about $2,334 in the U.K. to $19,607 in Switzerland.

$2M says home-based caregivers could use a little more AI in their day-to-day lives.